ArticleArthritis care & research2024

Latent Tuberculosis Screening Among New Users of a Biologic or Targeted Synthetic Disease-Modifying Antirheumatic Drug: Gaps in Screening Overall and Among Janus Kinase Inhibitors.

Eric T Roberts et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.